At the heart of the RainCity Analytics work is our strength in evidence synthesis and advanced analytics. From systematic reviews to complex comparative effectiveness analyses, we generate defensible evidence that stands up to peer review, HTA scrutiny, and regulatory decision-making.
Health economics is critical to ensure patients gain timely access to innovative treatments. Our team combines methodological depth with strategic insight to produce robust economic analyses and value communication that resonate with payers and policy-makers.
The best analysis has little impact if it isn’t communicated effectively. We specialize in translating rigorous methods and results into clear, engaging stories for scientific, clinical, and payer audiences.
Over the past decade, our systematic reviews and network meta-analyses have been foundational to WHO HIV treatment guidelines. These analyses informed the global switch from TLE to TLD regimens, affecting more than 20 million people, and led to multiple Lancet HIV publications.